Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 214

    1.

    The risk for myocardial infarction with cyclooxygenase-2 inhibitors.

    Pijak MR, Huzicka I, Gazdik F.

    Ann Intern Med. 2005 Oct 18;143(8):616-7; author reply 617-8. No abstract available. PMID: 16230736 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The risk for myocardial infarction with cyclooxygenase-2 inhibitors.

    Shinmura K, Bolli R.

    Ann Intern Med. 2005 Oct 18;143(8):617; author reply 617-8. No abstract available. PMID: 16230737 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The risk for myocardial infarction with cyclooxygenase-2 inhibitors.

    Kim JA, Choi YS, Yoon D, Cho KH.

    Ann Intern Med. 2005 Oct 18;143(8):615-6; author reply 617-8. No abstract available. PMID: 16230734 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Summaries for patients. Risk for heart attacks with different NSAIDs.

    [No authors listed]

    Ann Intern Med. 2005 Apr 5;142(7):I45. No abstract available. PMID: 15809454 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults.

    Lévesque LE, Brophy JM, Zhang B.

    Ann Intern Med. 2005 Apr 5;142(7):481-9.PMID: 15809459 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    [Cardiovascular ffects of COX-2 selective anti-inflammatory agents]

    Halinen MO.

    Duodecim. 2001;117(24):2570-1. Finnish. No abstract available. PMID: 12183817 [PubMed - indexed for MEDLINE]Related articles

    7.

    COX 2 inhibitors may increase risk of heart attack.

    Gottlieb S.

    BMJ. 2001 Sep 1;323(7311):471. No abstract available. PMID: 11532833 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Cox-2 inhibitors and cardiovascular risk: point and counterpoint.

    Mandell BF.

    Cleve Clin J Med. 2001 Nov;68(11):957-60. No abstract available. PMID: 11718436 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Efficacy and safety of aspirin in the long-term management of atherothrombosis.

    Patrono C.

    Haematologica. 2002 Jan;87(1):6-8. No abstract available. PMID: 11801459 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    FDA advisers warn: COX 2 inhibitors increase risk of heart attack and stroke.

    Lenzer J.

    BMJ. 2005 Feb 26;330(7489):440. No abstract available. PMID: 15731142 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.

    Baigent C, Patrono C.

    Arthritis Rheum. 2003 Jan;48(1):12-20. Review. No abstract available. PMID: 12528099 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Cardiovascular events and COX-2 inhibitors.

    Minic M.

    JAMA. 2001 Dec 12;286(22):2810; author reply 2811-2. No abstract available. PMID: 11735746 [PubMed - indexed for MEDLINE]Related articles

    13.

    COX-2 chronology.

    Hawkey CJ.

    Gut. 2005 Nov;54(11):1509-14.PMID: 16227351 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Cox-2 inhibitors and cardiovascular risk: we defend our data and suggest caution.

    Mukherjee D, Nissen SE, Topol EJ.

    Cleve Clin J Med. 2001 Nov;68(11):963-4. Review. No abstract available. PMID: 11718438 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Late preconditioning against myocardial stunning. Does aspirin close the "second window" of endogenous cardioprotection?

    Przyklenk K, Heusch G.

    J Am Coll Cardiol. 2003 Apr 2;41(7):1195-7. No abstract available. PMID: 12679221 [PubMed - indexed for MEDLINE]Related articles

    16.

    Reporting of clinical trials of analgesia.

    Katz N.

    J Thorac Cardiovasc Surg. 2004 Feb;127(2):605; author reply 606. No abstract available. PMID: 14762388 [PubMed - indexed for MEDLINE]Related articles

    17.

    [In high risk patients cyclooxygenase inhibitor plus proton pump inhibitor]

    Bolten WW.

    MMW Fortschr Med. 2003 Jan 30;145(5):9. German. No abstract available. PMID: 12619199 [PubMed - indexed for MEDLINE]Related articles

    18.

    The use of nonsteroidal anti-inflammatory drugs (NSAIDs): a science advisory from the American Heart Association.

    Bennett JS, Daugherty A, Herrington D, Greenland P, Roberts H, Taubert KA.

    Circulation. 2005 Apr 5;111(13):1713-6. Epub 2005 Mar 21. No abstract available. Erratum in: Circulation. 2005 Apr 5;111(13):1717. PMID: 15781731 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    MI risk prompts rofecoxib withdrawal.

    Thompson CA.

    Am J Health Syst Pharm. 2004 Nov 1;61(21):2234-6, 2238. No abstract available. PMID: 15552625 [PubMed - indexed for MEDLINE]Related articles

    20.

    Researchers plan to continue to study COX-2 inhibitors in cancer treatment and prevention.

    Vanchieri C.

    J Natl Cancer Inst. 2005 Apr 20;97(8):552-3. No abstract available. PMID: 15840872 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data